Difference between revisions of "IDRPublicationList"
From Clinfowiki
Line 2: | Line 2: | ||
== True positive == | == True positive == | ||
− | * ROSIGLITAZONE and claims study - Nationwide, observational, retrospective, inception cohort of 227,571 Medicare beneficiaries aged 65 years or older (mean age, 74.4 years) who initiated treatment with rosiglitazone or pioglitazone through a Medicare Part D prescription drug plan from July 2006-June 2009 and who underwent follow-up for up to 3 years after thiazolidinedione initiation. | + | * '''ROSIGLITAZONE and claims study''' SUMMARY: A claims analysis indicated increased risk of MI, stroke and health failure. This finding triggered trials meta-analysis that confirmed it. This lead to removing the drug from market. Without the IDR, we would still use that drug today. |
− | ** Graham DJ et al. Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone. JAMA doi:10.1001/jama.2010.920 http://www.ncbi.nlm.nih.gov/pubmed/20584880 | + | **ABSTRACT EXTRACT: Nationwide, observational, retrospective, inception cohort of 227,571 Medicare beneficiaries aged 65 years or older (mean age, 74.4 years) who initiated treatment with rosiglitazone or pioglitazone through a Medicare Part D prescription drug plan from July 2006-June 2009 and who underwent follow-up for up to 3 years after thiazolidinedione initiation. |
+ | **REFERENCE:Graham DJ et al. Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone. JAMA doi:10.1001/jama.2010.920 http://www.ncbi.nlm.nih.gov/pubmed/20584880 | ||
**** http://en.wikipedia.org/wiki/Rosiglitazone | **** http://en.wikipedia.org/wiki/Rosiglitazone | ||
− | * CIMETIDINE and drug repurposing | + | * '''CIMETIDINE and drug repurposing''' SUMMARY: Database finding revealed possible second use of a drug. This database finding lead to a mouse model experiment(confirmed effect) (clinical trial started [documentation missing]. Without the IDR/database, we would never discover the additional therapeutic effect. |
− | ** cimetidine and lung cancer http://www.ncbi.nlm.nih.gov/pubmed/21849665 | + | ** REFERENCE:cimetidine and lung cancer http://www.ncbi.nlm.nih.gov/pubmed/21849665 |
− | * thanks to | + | * thanks to an IDR, we were able to complete this trial (anecdotal, no PMID available) |
== False positive == | == False positive == |
Revision as of 18:02, 10 April 2013
List of publications that report use of an Integrated Data Repository (IDR). ("IDR success stories")
True positive
- ROSIGLITAZONE and claims study SUMMARY: A claims analysis indicated increased risk of MI, stroke and health failure. This finding triggered trials meta-analysis that confirmed it. This lead to removing the drug from market. Without the IDR, we would still use that drug today.
- ABSTRACT EXTRACT: Nationwide, observational, retrospective, inception cohort of 227,571 Medicare beneficiaries aged 65 years or older (mean age, 74.4 years) who initiated treatment with rosiglitazone or pioglitazone through a Medicare Part D prescription drug plan from July 2006-June 2009 and who underwent follow-up for up to 3 years after thiazolidinedione initiation.
- REFERENCE:Graham DJ et al. Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone. JAMA doi:10.1001/jama.2010.920 http://www.ncbi.nlm.nih.gov/pubmed/20584880
- CIMETIDINE and drug repurposing SUMMARY: Database finding revealed possible second use of a drug. This database finding lead to a mouse model experiment(confirmed effect) (clinical trial started [documentation missing]. Without the IDR/database, we would never discover the additional therapeutic effect.
- REFERENCE:cimetidine and lung cancer http://www.ncbi.nlm.nih.gov/pubmed/21849665
- thanks to an IDR, we were able to complete this trial (anecdotal, no PMID available)
False positive
Example of a published findings in an IDR that later turned out to be false. E.g., reporting an effect of a drug (or other findings) from an IDR analysis, but later human trials or other experiments did not validate it.
- tbd